Right ventricular and right atrial involvement can predict atrial fibrillation in patients with hypertrophic cardiomyopathy?

International Journal of Medical Sciences

Volumn 13, Issue 1, 2016, Pages 1-7

  Doesch, Christina ^a,b   Lossnitzer, Dirk ^a,b   Rudic, Boris ^a,b   Tueluemen, Erol ^a,b   Budjan, Johannes ^a,b   Haubenreisser, Holger ^a,b   Henzler, Thomas ^a,b   Schoenberg, Stefan O ^a,b   Borggrefe, Martin ^a,b   Papavassiliu, Theano ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Atrial fibrillation; Cardiovascular magnetic resonance imaging; Hypertrophic cardiomyopathy; Late gadolinium enhancement; MAPSE; TAPSE

Indexed keywords

GADOLINIUM; GADOTERIC ACID; CONTRAST MEDIUM;

ADULT; AREA UNDER THE CURVE; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ATRIUM ENLARGEMENT; HEART LEFT VENTRICLE MASS; HEART RIGHT ATRIUM; HEART RIGHT VENTRICLE; HOLTER MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LEFT VENTRICULAR REMODELING INDEX; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; NUCLEAR MAGNETIC RESONANCE SCANNER; PERFORMANCE; PREDICTION; RADIOLOGICAL PARAMETERS; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEPTAL MITRAL ANNULAR PLANE SYSTOLIC EXCURSION; SINUS RHYTHM; TRICUSPID ANNULAR PLANE SYSTOLIC EXCURSION; AGED; CHEMISTRY; DIAGNOSTIC IMAGING; HEART ATRIUM; HEART VENTRICLE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; RADIOGRAPHY;

ADULT; AGED; ATRIAL FIBRILLATION; CARDIOMYOPATHY, HYPERTROPHIC; CONTRAST MEDIA; FEMALE; GADOLINIUM; HEART ATRIA; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RADIOGRAPHY;

EID: 84953277891     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.13530     Document Type: Article

References (20)

1. Morner S, Lindqvist P, Waldenstrom A, et al. Right ventricular dysfunction in hypertrophic cardiomyopathy as evidenced by the myocardial performance index. Int J Cardiol. 2008; 124: 57-63.
2. Kaul S, Tei C, Hopkins JM, et al. Assessment of right ventricular function using two-dimensional echocardiography. Am Heart J. 1984; 107: 526-531.
3. Wenzelburger FW, Tan YT, Choudhary FJ, et al. Mitral annular plane systolic excursion on exercise: a simple diagnostic tool for he art failure with preservedejection fraction. Eur J Heart Fail. 2011; 13: 953-960.
4. Olivotto I, Cecchi F, Casey SA, et al. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001; 104: 2517-2524.
5. Papavassiliu T, Germans T, Fluchter S, et al. CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation. J Cardiovasc Magn Reson. 2009; 11: 34.
6. Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006; 113: 1807-1816.
7. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001; 218: 215-223.
8. Sievers B, Kirchberg S, Addo M, et al. Assessment of left atrial volumes in sinus rhythm and atrial fibrillation using the biplane area-length method and cardiovascular magnetic resonance imaging with TrueFISP. J Cardiovasc Magn Reson. 2004; 6: 855-863.
9. Gelfand EV, Hughes S, Hauser TH, et al. Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance: optimizing correlation with Doppler echocardiography. J Cardiovasc Magn Reson. 2006; 8: 503-507.
10. Bruch C, Stypmann J, Gradaus R, et al. Usefulness of tissue Doppler imaging for estimation of filling pressures in patients with primary or secondary pure mitral regurgitation. Am J Cardiol. 2004; 93: 324-328.
11. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010; 31: 2369-2429.
12. Cecchi F, Olivotto I, Montereggi A, et al. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol. 1995; 26: 1529-1536.
13. Losi MA, Betocchi S, Aversa M, et al. Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2004; 94: 895-900.
14. Maron BJ, Haas TS, Maron MS, et al. Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance. Am J Cardiol. 2014; 113: 1394-1400.
15. Yamaji K, Fujimoto S, Yutani C, et al. Does the progression of myocardial fibrosis lead to atrial fibrillation in patients with hypertrophic cardiomyopathy? Cardiovasc Pathol. 2001; 10: 297-303.
16. McKenna WJ, Kleinebenne A, Nihoyannopoulos P, et al. Echocardiographic measurement of right ventricular wall thickness in hypertrophic cardiomyopathy: relation to clinical and prognostic features. J Am Coll Cardiol. 1988; 11: 351-358.
17. Scott AD, Keegan J, and Firmin DN. Motion in cardiovascular MR imaging. Radiology. 2009; 250: 331-351.
18. Serri K, Reant P, Lafitte M, et al. Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2006; 47: 1175-1181.
19. Levy S, Breithardt G, Campbell RW, et al. Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J. 1998; 19: 1294-1320.
20. Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003; 42: 1687-1713.